Literature DB >> 11238683

Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.

H Kanayama 1, W O Lui, M Takahashi, T Naroda, D Kedra, F K Wong, Y Kuroki, Y Nakahori, C Larsson, S Kagawa, B T Teh.   

Abstract

Four cases of late onset clear cell renal cell carcinoma (RCC), a case of gastric cancer, and a case of exocrine pancreatic cancer were identified in a Japanese family. In order to elucidate the underlying mechanism for tumorigenesis in this family, extensive genetic studies were performed including routine and spectral karyotyping (SKY), fluorescence in situ hybridisation (FISH), comparative genomic hybridisation (CGH), loss of heterozygosity studies (LOH), and VHL mutation analysis. A germline translocation t(1;3)(q32-q41;q13-q21) was identified by karyotyping in five members of the family including all three RCC cases tested. The translocation was refined to t(1;3)(q32;q13.3) by FISH analysis using locus specific genomic clones, and the two breakpoints were mapped to a 5 cM region in 3q13.3 and a 3.6 cM region in 1q32. Both CGH and allelotyping using microsatellite markers showed loss of the derivative chromosome 3 carrying a 1q segment in the three familial RCCs analysed. Additional chromosomal imbalances were identified by CGH, including amplifications of chromosomes 5 and 7 and loss of 8p and 9. No germline VHL mutation was found but two different somatic mutations, a splice (IVS1-2A>C) and a frameshift (726delG), were identified in two RCCs from the same patient confirming their distinct origin. Taken together, these results firmly support a three step model for tumorigenesis in this family. A constitutional translocation t(1q;3q) increased the susceptibility to loss of the derivative chromosome 3 which is then followed by somatic mutations of the RCC related tumour suppressor gene VHL located in the remaining copy of chromosome 3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238683      PMCID: PMC1734822          DOI: 10.1136/jmg.38.3.165

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  27 in total

1.  An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation.

Authors:  D Bodmer; M J Eleveld; M J Ligtenberg; M A Weterman; B A Janssen; D F Smeets; P E de Wit; A van den Berg; E van den Berg; M I Koolen; A Geurts van Kessel
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Familial non-VHL non-papillary clear-cell renal cancer.

Authors:  B T Teh; S Giraud; N F Sari; S I Hii; J P Bergerat; C Larsson; J M Limacher; D Nicol
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

3.  A familial case of renal cell carcinoma and a t(2;3) chromosome translocation.

Authors:  M I Koolen; A P van der Meyden; D Bodmer; M Eleveld; E van der Looij; H Brunner; A Smits; E van den Berg; D Smeets; A Geurts van Kessel
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

4.  FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.

Authors:  P Bugert; M Wilhelm; G Kovacs
Journal:  Genes Chromosomes Cancer       Date:  1997-09       Impact factor: 5.006

5.  Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.

Authors:  J R Toro; G Glenn; P Duray; T Darling; G Weirich; B Zbar; M Linehan; M L Turner
Journal:  Arch Dermatol       Date:  1999-10

6.  Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.

Authors:  T Kuukasjärvi; M Tanner; S Pennanen; R Karhu; T Visakorpi; J Isola
Journal:  Genes Chromosomes Cancer       Date:  1997-02       Impact factor: 5.006

7.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.

Authors:  P Bugert; G Kovacs
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

8.  Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.

Authors:  B T Teh; F Farnebo; U Kristoffersson; B Sundelin; J Cardinal; R Axelson; A Yap; M Epstein; H Heath; D Cameron; C Larsson
Journal:  J Clin Endocrinol Metab       Date:  1996-12       Impact factor: 5.958

9.  A cross sectional study of renal involvement in tuberous sclerosis.

Authors:  J A Cook; K Oliver; R F Mueller; J Sampson
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

10.  The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Authors:  M Ohta; H Inoue; M G Cotticelli; K Kastury; R Baffa; J Palazzo; Z Siprashvili; M Mori; P McCue; T Druck; C M Croce; K Huebner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

View more
  5 in total

1.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

Review 3.  Familial adult renal neoplasia.

Authors:  M Takahashi; R Kahnoski; D Gross; D Nicol; B T Teh
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

Review 4.  Hereditary kidney cancer syndromes.

Authors:  Naomi B Haas; Katherine L Nathanson
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

5.  Epidemiology of kidney cancer.

Authors:  D Pascual; A Borque
Journal:  Adv Urol       Date:  2008-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.